Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,109 INR | -0.26% | +0.27% | +6.58% |
16/05 | Transcript : Mankind Pharma Limited, Q4 2024 Earnings Call, May 16, 2024 | |
16/05 | Mankind Pharma's Consolidated Profit Jumps in Fiscal Q4 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.58% | 1.02TCr | |
+38.59% | 73TCr | |
-7.89% | 35TCr | |
+15.66% | 32TCr | |
+0.24% | 27TCr | |
+13.09% | 24TCr | |
+6.96% | 20TCr | |
-6.50% | 20TCr | |
+4.23% | 16TCr | |
-1.70% | 16TCr |
- Stock Market
- Equities
- MANKIND Stock
- News Mankind Pharma Limited
- Jefferies Adjusts Mankind Pharma's Price Target to INR1,870 From INR1,830, Keeps at Hold